Exosome
CD31
Antibodies Panel
IR295-2 anti-Tissue Factor / CD142 antibody WB image
Catalog Number:IR295-2

Tissue Factor / CD142 antibody

Application
  • WB
  • IF
  • IHC
Reactivity Hu

REACTIVITYHu
SENSITIVITYEndogenous
MW45-53, >110
SOURCERabbit-IgG

Product Includes

-

Application Dilution

Western Blot 1:1000-1:2000
Immunofluorescence 1:300-1:600
Immunohistochemistry (Paraffin) 1:100–1:300

Storage

Store at +4°C for short term storage. Long time storage is recommended at -20°C
100mM Tris Glycine, 20% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative

Specificity / Sensitivity

Endogenous

Source / Immunogen

Synthetic peptide / Extracellular domain corresponding to Human Tissue Factor / CD142

This gene encodes coagulation factor III which is a cell surface glycoprotein. This factor enables cells to initiate the blood coagulation cascades, and it functions as the high-affinity receptor for the coagulation factor VII. The resulting complex provides a catalytic event that is responsible for initiation of the coagulation protease cascades by specific limited proteolysis. Unlike the other cofactors of these protease cascades, which circulate as nonfunctional precursors, this factor is a potent initiator that is fully functional when expressed on cell surfaces, for example, on monocytes. There are 3 distinct domains of this factor: extracellular, transmembrane, and cytoplasmic. Platelets and monocytes have been shown to express this coagulation factor under procoagulatory and proinflammatory stimuli, and a major role in HIV-associated coagulopathy has been described. Platelet-dependent monocyte expression of coagulation factor III has been described to be associated with Coronavirus Disease 2019 (COVID-19) severity and mortality. This protein is the only one in the coagulation pathway for which a congenital deficiency has not been described. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Aug 2020]

Title
No data.

Reviews

Please login before enter the comment!